SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-010345
Filing Date
2024-02-05
Accepted
2024-02-05 07:00:09
Documents
4
Period of Report
2024-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2334005d11_6k.htm 6-K 12616
2 EXHIBIT 99.1 tm2334005d11_99-1.htm EX-99.1 238486
3 EXHIBIT 99.2 tm2334005d11_99-2.htm EX-99.2 92950
4 EXHIBIT 99.3 tm2334005d11_99-3.htm EX-99.3 96767
  Complete submission text file 0001104659-24-010345.txt   441855
Mailing Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970
Business Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970 004531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 24593918
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)